Skip to main content
Top

Breast Cancer Research and Treatment

Issue 1/1997

Content (11 Articles)

Enhanced anti-proliferative activity of the combination of tamoxifen plus HER-2-neu antibody

Lois M. Witters, Rakesh Kumar, Vernon M. Chinchilli, Allan Lipton

Seasonal variation in the secretion of mammotrophic hormones in normal women and women with previous breast cancer

I.M. Holdaway, B.H. Mason, E.E. Gibbs, C. Rajasoorya, A. Lethaby, K.D. Hopkins, M.C. Evans, T. Lim, B. Schooler

Bone marrow micrometastases in 109 breast cancer patients: Correlations with clinical and pathological features and prognosis

Annamaria Molino, Giuseppe Pelosi, Monica Turazza, Loris Sperotto, Andrea Bonetti, Rolando Nortilli, Giovanni Fattovich, Cristoforo Alaimo, Quirino Piubello, Flavia Pavanel, Rocco Micciolo, Gian Luigi Cetto

Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells

Maura Simboli-Campbell, Carmen J. Narvaez, Kathryn VanWeelden, Martin Tenniswood, JoEllen Welsh

Influence of estrogen metabolism on proliferation of human breast cancer

Shigeru Imoto, Fumiko Mitani, Kohji Enomoto, Kiyoshi Fujiwara, Tadashi Ikeda, Masaki Kitajima, Yuzuru Ishimura

P-glycoprotein: The intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer

Hyun Cheol Chung, Sun Young Rha, Joo Hang Kim, Jae Kyung Roh, Jin Sik Min, Kyung Sik Lee, Byung Soo Kim, Kyi Beom Lee

Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells

Yue Huang, Swapan Ray, John C. Reed, Ana Maria Ibrado, Caroline Tang, Amir Nawabi, Kapil Bhalla

Epidermal growth factor in plasma and saliva of patients with active breast cancer and breast cancer patients in follow-up compared with healthy women

Miguel A. Navarro, Ricard Mesía, Orland Díez-Gibert, Antonio Rueda, Belén Ojeda, María C. Alonso

Magnetic resonance galactography for a patient with nipple discharge

Masataka Yoshimoto, Fujio Kasumi, Takuji Iwase, Kaoru Takahashi, Takashi Tada, Yoshihiro Uchida

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine